Solanezumab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Solanezumab, covering 2010-06-02 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) [Phase 2, Phase 3]